Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin vs sulphonylurea during Ramadan in Muslim patients with type 2 diabetes
2008-002607-12Phase 4Terminated
- Sponsor
- Central Manchester University Hospitals NHS Foundation Trust
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sitagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Central Manchester University Hospitals NHS Foundation Trust. Primary endpoint: Incidence of hypoglycemia. Started Jul 2008; status: terminated.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-002607-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002607-12.